Dateline Resources (ASX:DTR) loses its stay bid as the Colosseum injunction heads to the Ninth Circuit, with the US Government backing the appeal.

Anthropic IPO filing reveals US$895 billion in AI commitments, US$17 billion quarterly revenue and a US$23.3 billion net loss. What investors should know.

Janus Electric (ASX:JNS) lodges 16 more California HVIP applications as US conversion coverage expands to 920 Class 8 truck configurations.

QMines (ASX:QML) raises A$5.5 million at 5.2 cents in a placement backed by QIC, strengthening funding for the Mt Chalmers DFS and drilling.

Blockbuster drugs cannot last forever and Exelixis (NDQ:EXEL) is a company facing up to that reality. Exelixis built its reputation on cabozantinib, a ...

Another RBA rate hike, the 5th (!) this year, and it may still not be enough to reign in the effects of Labor's excessive spending ... thanks Chalmers!

Reedy Lagoon (ASX:RLC) seeks shareholder approval for Tranche 2 of a A$700,000 placement priced at A$0.00125, lifting share count by 25%.

Halozyme Therapeutics is a company that changed trajectory during 2026. It entered the year as a biologics‑delivery specialist but is a royalty compounder.

Marvell (MRVL) stock plunged 10% after announcing a US$115 billion Lumentum AI deal. See the acquisition terms, shareholder dilution and investor concerns.

Oracle (ORCL) stock fell nearly 7% intraday as its US$20 billion AI financing plan raised dilution fears. Explore the share sale, debt risks and cash flow outlook.

Nvidia (NVDA) stock enters Monday after a 4.22% drop as AI spending fears grow. See how AMD and Arista earnings could shape semiconductor stocks this week.

Skylark Minerals (ASX:SKM) raised A$20m at a premium with PDI Gold taking a 9.9% strategic stake ahead of 2027 Zaranou ...